Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer's chaotic year wraps up with plunging stock, grim guidance
06:25am, Thursday, 21'st Dec 2023
Investors who own Pfizer Inc. NYSE: PFE may have expected 2023 to be what football teams call a "rebuilding year." The company shifted its focus away from COVID-19 drugs and toward potential deals, sh
Better Bull Market Buy: CRISPR Therapeutics vs. Pfizer Stock
05:51am, Thursday, 21'st Dec 2023
CRISPR Therapeutics just reached a major milestone: approval of its first product. Pfizer is cheap and could deliver market-beating total returns thanks to its juicy dividend.
Pfizer: Buy The Panic
01:08am, Thursday, 21'st Dec 2023
Pfizer stock has fallen 45% YTD as it has been impacted by the decline in revenue from COVID-19 products. The recent news about Danuglipron has added fuel to the fire. But is everything so bad when it
Pfizer Is Not Cheap, And The 5.7% Yield Is Not As Safe As You Might Think
01:46pm, Wednesday, 20'th Dec 2023
Pfizer's stock reached an all-time high in 2021 due to high demand for its COVID-19 vaccine but has since declined by 45% year-to-date. The company has revised its financial guidance for FY24, expecti
Better Dividend Stock: Pfizer or British American Tobacco?
08:45am, Wednesday, 20'th Dec 2023
Pfizer and British American Tobacco are blue chip dividend stocks with high yields. Pfizer faces revenue headwinds due to declining sales of its COVID-19 products.
Pfizer (PFE) Stock Rises on FDA Nod for Expanded Use of Padcev
12:02pm, Tuesday, 19'th Dec 2023
The FDA approves Pfizer's (PFE) Padcev in combination with Merck's (MRK) Keytruda for adult patients with advanced bladder cancer. Stock rises 1.6%.
5 Dividend Stocks That Could Deliver Life-Changing Returns
11:25am, Tuesday, 19'th Dec 2023
The company offers medicines and vaccines in various therapeutic areas, including: Cardiovascular metabolic and women's health under the Premarin family and Eliquis brands Biologics, small molecules,
Why Pfizer Stock Is Bouncing Back
11:23am, Tuesday, 19'th Dec 2023
Pfizer issued weak guidance last week. Investors got spooked -- but today they're getting excited.
Pfizer Invites Public to View and Listen to Webcast of January 30 Conference Call with Analysts
10:00am, Tuesday, 19'th Dec 2023
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, Jan
Pfizer (PFE) Beats Stock Market Upswing: What Investors Need to Know
06:47pm, Monday, 18'th Dec 2023
The latest trading day saw Pfizer (PFE) settling at $27.06, representing a +1.61% change from its previous close.
3 Stocks That Just Hit a 52-Week Low. Time to Back Up the Truck?
06:44pm, Monday, 18'th Dec 2023
Dumpster diving can be fun when looking for beaten-down stocks to buy. Many times deeply discounted companies are simply mispriced by the market.
Why Pfizer Stock Was a Winner on Monday
06:08pm, Monday, 18'th Dec 2023
The healthcare giant won FDA approval for its cancer drug, to be used in combination with another treatment. Padcev earned the approval for the treatment of bladder cancer.
Pfizer Slashed Its Guidance, but Is It Still a Smart Long-Term Buy?
09:30am, Monday, 18'th Dec 2023
Pfizer just issued updated financial guidance, and it's not great. But its plans over the rest of this decade will likely turn things around.
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?
09:15am, Monday, 18'th Dec 2023
Understanding what's hot and what's not is key to investing in biopharma. Drugs like Ozempic are going to continue being very popular next year.
3 of the Most Attractive Dividend Stocks in the Pharma Space
02:00pm, Sunday, 17'th Dec 2023
In the realm of investment, pharma dividend stocks are a beacon for both stability and growth. This sector not only enhances the quality of life on a global scale but also presents lucrative opportuni
